TORONTO, Canada — January 14, 2026 — Leads & Copy —
Visionary Holdings Inc. (Nasdaq: GV) has released its final annual report and audited financial statements for the fiscal year ended March 31, 2025.
The company’s Annual Report on Form 20-F has not yet been filed with the U.S. Securities and Exchange Commission (SEC). The company is transitioning from education and real estate to health management, anti-aging, premium medical aesthetics, and AI-enabled education.
Emerging health-related businesses generated initial revenue during the fiscal year.
Total revenue for fiscal year 2025 was USD 5.04 million, a 46.2% year-over-year decrease, attributed to real estate leasing contraction and education policy changes. Revenue included:
Real estate leasing: USD 2.80 million
Education services: USD 1.18 million
Life sciences and health-related businesses: USD 1.06 million
Emerging businesses accounted for 21.1% of total revenue.
The company reported a net loss of USD 15.75 million, reflecting transformation-related investments, USD 4.70 million in asset impairment charges, and financing costs. Gross margin improved to 28.0%, with education services at 64.4%. Cash flow from investing activities was USD 14.51 million, from asset dispositions. Operating cash outflows decreased to USD 2.97 million.
As of March 31, 2025, total assets were USD 63.63 million. The company is addressing loan defaults and negative working capital through equity financing and debt restructuring negotiations. The company faces liquidity and financing pressures.
In health management, the company is focusing on gastrointestinal health management. In anti-aging and medical aesthetics, the company is exploring service-driven solutions. Collaborations include Jiangsu Yike Regenerative Medicine Technology Co., Ltd. and Anhui Weikang Kangling Medical Technology Co., Ltd.
The AI education business remained stable, offering Ontario Secondary School Diploma (OSSD) programs and vocational education.
Mr. Xiyong Hou, Chief Executive Officer of Visionary Holdings, said that fiscal year 2025 marked a critical phase, and the company will focus on premium medical aesthetics and cellular rejuvenation-related businesses.
The company aims to strengthen corporate governance and internal controls.
The company will explore commercialization opportunities in health management, anti-aging, and medical aesthetics; optimize the AI education ecosystem; and strengthen corporate governance and internal control systems.
Visionary Holdings Inc. is headquartered in Toronto, Canada, and operates through subsidiaries in North America and Asia.
Contacts:
Visionary Holdings Inc.
Investor Relations
Email: IR@visionary.holdings
Telephone: +1 905-305-1881
Source: Visionary Holdings Inc.
